Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 2.5mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 5mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 7.5mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 10mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 15mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 20mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. | |
Product: | Lenalidomide Te Arai |
Active Ingredient: | Lenalidomide 25mg |
Dosage Form: | Capsule |
New Zealand Sponsor: | Te Arai BioFarma Limited |
Manufacturer: | Lotus Pharmaceutical Co, Limited, Nantou City, Taiwan |
Note: This consent is given subject to the following conditions:
|
|
Also note: This consent is valid for two years from the date of publication of this notice. |
Dated this 21st day of October 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).